Teladoc Health (NYSE:TDOC) Price Target Cut to $9.00

Teladoc Health (NYSE:TDOC) had its price objective dropped by equities research analysts at Stifel Nicolaus from $16.00 to $9.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has a “hold” rating on the health services provider’s stock. Stifel Nicolaus’ target price indicates a potential upside of 2.51% from the stock’s current price.

Several other research analysts also recently issued reports on the company. TD Cowen lowered their price objective on Teladoc Health from $16.00 to $15.00 and set a “hold” rating for the company in a research note on Friday, April 26th. Canaccord Genuity Group cut their price target on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a report on Thursday. Oppenheimer decreased their price objective on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a report on Thursday. Royal Bank of Canada cut their target price on Teladoc Health from $25.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, April 26th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research report on Friday, April 26th. Thirteen equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $16.16.

Teladoc Health Price Performance

Shares of NYSE TDOC traded down $0.65 during mid-day trading on Thursday, hitting $8.78. 10,164,420 shares of the stock traded hands, compared to its average volume of 5,368,042. The company has a market cap of $1.49 billion, a PE ratio of -6.23 and a beta of 0.94. Teladoc Health has a twelve month low of $8.13 and a twelve month high of $27.36. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74. The firm has a 50 day simple moving average of $10.06 and a two-hundred day simple moving average of $13.85.

Insiders Place Their Bets

In other news, Director Karen L. Daniel sold 9,834 shares of the business’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total transaction of $117,024.60. Following the completion of the sale, the director now owns 36,995 shares in the company, valued at $440,240.50. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Over the last quarter, insiders have sold 15,388 shares of company stock worth $178,225. Corporate insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently made changes to their positions in TDOC. Hexagon Capital Partners LLC raised its stake in shares of Teladoc Health by 204.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after purchasing an additional 1,065 shares during the last quarter. Allianz Asset Management GmbH grew its holdings in Teladoc Health by 15.4% during the fourth quarter. Allianz Asset Management GmbH now owns 604,238 shares of the health services provider’s stock worth $13,021,000 after buying an additional 80,805 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Teladoc Health by 74.0% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock valued at $311,000 after acquiring an additional 8,750 shares in the last quarter. Janney Montgomery Scott LLC boosted its holdings in Teladoc Health by 188.7% during the 1st quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider’s stock worth $477,000 after acquiring an additional 20,651 shares during the last quarter. Finally, Vanguard Group Inc. grew its stake in shares of Teladoc Health by 11.8% in the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock worth $377,451,000 after acquiring an additional 1,855,480 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.